Historical record - last NADAC effective date: 5/1/2024
Product Information
METHYLPHENIDATE 20 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1389 per EA under NDC 43386057501. Its NADAC has been published 427 times since Mar 9, 2016.
FDA first approved this application on Nov 13, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
43386057501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
5/1/2024
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207884FDA Approved
11/13/2015
TE Code
AB
On Market Since
11/13/2015
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE 20 MG TABLET has been published 427 times since Mar 9, 2016, and over the history we have for it it has declined 84.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1389 per EA |
|---|---|
| All-time high | $0.9012 (Apr 13, 2016) |
| All-time low | $0.1079 (Apr 17, 2024) |
| Median price | $0.2681 |
| Average price | $0.3708 |
| Largest weekly change | -50.1% (Apr 17, 2024) |
| Weeks tracked | 427 |
| Tracking since | Mar 9, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-18.3%
5Y
-34.5%
All
-84.2%
Last surveyed May 8, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 20 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.1389 per EA (NDC 43386057501), effective May 8, 2024.
How has the price of METHYLPHENIDATE 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE 20 MG TABLET has declined 84.2%. It has been tracked across 427 weekly CMS publications since Mar 9, 2016.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 20 MG TABLET?
Since Mar 9, 2016, the NADAC for METHYLPHENIDATE 20 MG TABLET has ranged from a low of $0.1079 (Apr 17, 2024) to a high of $0.9012 (Apr 13, 2016), with a median of $0.2681 per EA.
Are there cheaper alternatives to METHYLPHENIDATE 20 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHYLPHENIDATE 20 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METHYLPHENIDATE 20 MG TABLET?
METHYLPHENIDATE 20 MG TABLET (NDC 43386057501) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.